HU-308 - a synthetic cannabinoid (CB2 agonist) studies completed
Overview
The abbreviation "HU" stands for Hebrew University.

Science and Research
2011 - Study ~ Gadolinium-HU-308-incorporated micelles.
2011 - Study ~ CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling
2008 - Study ~ Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor
2007 - Interview ~ Endocannabinoids, cannabinoid receptors and inflammatory stress: an interview with Dr. Pál Pacher2006 - Study ~ Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
2006 - News - Activation of CB2 receptor attenuates bone loss in osteoporosis
2005 - Study - Peripheral cannabinoid receptor, CB2, regulates bone mass
2005 - Study ~ Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
2005 - Study ~ Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.
1999 - Study ~ HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.